ELAN financial statements
The full income statement, balance sheet, and cash-flow statement for Elanco Animal Health Incorporated (ELAN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 4.71B YoY+6.2% | 4.44B YoY+0.5% | 4.42B YoY+0.1% | 4.41B YoY-7.4% | 4.76B YoY+45.6% | |
2.59B YoY+6.4% | 2.44B YoY-2.0% | 2.49B | — | — | ||
| Research & development | 368M YoY+7.0% | 344M YoY+5.2% | 327M YoY+1.9% | 321M YoY-13.0% | 369M YoY+12.2% | |
| Selling, general & administrative | 1.43B YoY+8.8% | 1.31B YoY+2.3% | 1.28B YoY+1.6% | 1.26B YoY-9.8% | 1.40B YoY+40.7% | |
| Restructuring | 156M YoY+254.5% | 44.0M | 0.00 YoY+100.0% | -7.00M YoY-106.4% | 110M YoY-29.9% | |
| Amortization of intangibles | 543M YoY+3.0% | 527M YoY-3.8% | 548M YoY+3.8% | 528M YoY-5.0% | 556M YoY+54.4% | |
| Interest expense | — | — | 277M YoY+14.9% | 241M YoY+2.1% | 236M YoY+57.3% | |
| Interest & investment income | 43.0M YoY+38.7% | 31.0M YoY+675.0% | 4.00M | — | — | |
| Other non-operating income | — | — | -75.0M YoY-134.4% | -32.0M YoY-540.0% | -5.00M YoY-102.8% | |
| Pre-tax income | -224M YoY-145.9% | 488M YoY+140.8% | -1.20B YoY-1559.7% | -72.0M YoY+87.4% | -571M YoY+15.7% | |
| Income tax | 8.00M YoY-94.7% | 150M YoY+316.7% | 36.0M YoY+500.0% | 6.00M YoY+106.8% | -88.0M YoY+14.6% | |
| Net income | -232M YoY-168.6% | 338M YoY+127.5% | -1.23B YoY-1478.2% | -78.0M YoY+83.9% | -483M YoY+15.9% | |
-$0.47 YoY-169.1% | $0.68 YoY+127.2% | -$2.50 YoY-1462.5% | -$0.16 YoY+83.8% | -$0.99 YoY+23.8% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
3.46B YoY+7.6% | 3.21B YoY-5.6% | 3.41B YoY+3.9% | 3.28B YoY+0.2% | 3.27B YoY-4.2% | ||
13.4B YoY+5.9% | 12.6B YoY-12.2% | 14.4B YoY-7.3% | 15.5B YoY-6.0% | 16.5B YoY-6.9% | ||
1.60B YoY+21.4% | 1.31B YoY+6.0% | 1.24B YoY-27.1% | 1.70B YoY+3.3% | 1.65B YoY-20.7% | ||
6.81B YoY+4.5% | 6.52B YoY-19.9% | 8.14B YoY-0.8% | 8.20B YoY-8.6% | 8.97B YoY-2.7% | ||
6.55B YoY+7.4% | 6.10B YoY-2.0% | 6.22B YoY-14.6% | 7.29B YoY-2.9% | 7.51B YoY-11.2% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
560M YoY+3.5% | 541M YoY+99.6% | 271M YoY-40.0% | 452M YoY-6.4% | 483M YoY+1278.0% | ||
-279M YoY-124.1% | 1.16B YoY+785.2% | -169M YoY+5.6% | -179M YoY+66.2% | -530M YoY+88.9% | ||
-275M YoY+81.6% | -1.49B YoY-1697.6% | -83.0M YoY+84.9% | -549M YoY-361.4% | 210M YoY-95.8% | ||
| FX effect on cash | 71.0M YoY+178.0% | -91.0M YoY-658.3% | -12.0M YoY+29.4% | -17.0M YoY+45.2% | -31.0M YoY-214.8% | |
| Net change in cash | 77.0M YoY-33.6% | 116M YoY+1557.1% | 7.00M YoY+102.4% | -293M YoY-322.0% | 132M YoY-18.0% | |
| Interest paid | 206M YoY-30.4% | 296M YoY-21.9% | 379M YoY+42.5% | 266M YoY+20.4% | 221M YoY+68.7% | |
| Income taxes paid | 225M YoY+60.7% | 140M YoY+47.4% | 95.0M YoY+2.2% | 93.0M YoY-38.4% | 151M YoY+55.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 11.3B YoY+87.8% | 5.99B YoY-18.4% | 7.34B YoY+26.7% | 5.79B YoY-56.8% | 13.4B YoY-7.3% | |
| P/E | — | 17.7× | — | — | — | |
| P/S | 2.4× YoY+76.8% | 1.3× YoY-19.7% | 1.7× YoY+31.7% | 1.3× YoY-54.7% | 2.8× YoY-36.3% | |
| P/B | 1.7× YoY+74.9% | 1.0× YoY-17.9% | 1.2× YoY+38.7% | 0.9× YoY-51.7% | 1.8× YoY+4.5% | |
| P/FCF | 39.6× YoY+160.6% | 15.2× | — | 11.8× YoY-71.6% | 41.4× | |
— | 5.6% | — | — | — | ||
2.5% YoY-61.6% | 6.6% | — | 8.5% YoY+251.9% | 2.4% | ||
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ELAN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ELAN filings on SEC EDGAR → Not investment advice.
